Amanote Research
Register
Sign In
P1.13-02 eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.858
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
L. Horn
Y. Wu
M. Reck
H. Wakelee
C. Liang
K. Harrow
V. Oertel
T. Mok
Publisher
Elsevier BV